Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionIndependent Advisor Alliance
Latest Disclosed Ownership33,486 shares
Latest Disclosed Value $ 4,666,832
Independent Advisor Alliance reports 1.37% increase in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - Independent Advisor Alliance filed a 13F-HR form disclosing ownership of 33,486 shares of Gilead Sciences, Inc. (CH:GILD) valued at $4,666,832 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 33,032 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.37% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F GILEAD SCIENCES COM 375558103 33,486 454 1.37 4,667 15.10 0.0284
2026-02-04 2025-12-31 13F GILEAD SCIENCES COM 375558103 33,032 -338 -1.01 4,054 9.45 0.0985
2025-11-04 2025-09-30 13F GILEAD SCIENCES COM 375558103 33,370 350 1.06 3,704 1.20 0.0963
2025-08-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 33,020 -1,415 -4.11 3,661 -5.13 0.1056
2025-05-12 2025-03-31 13F GILEAD SCIENCES COM 375558103 34,435 2,307 7.18 3,858 30.03 0.1274
2025-02-07 2024-12-31 13F GILEAD SCIENCES COM 375558103 32,128 8,398 35.39 2,968 49.17 0.0393
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 23,730 270 1.15 1,990 23.62 0.0724
2024-08-12 2024-06-30 13F GILEAD SCIENCES COM 375558103 23,460 6,594 39.10 1,610 30.28 0.0551
2024-05-08 2024-03-31 13F GILEAD SCIENCES COM 375558103 16,866 1,513 9.85 1,235 -0.64 0.0446
2024-02-08 2023-12-31 13F GILEAD SCIENCES COM 375558103 15,353 975 6.78 1,244 15.41 0.0448
2023-10-24 2023-09-30 13F GILEAD SCIENCES COM 375558103 14,378 7,794 118.38 1,077 112.43 0.0487
2023-07-28 2023-06-30 13F GILEAD SCIENCES COM 375558103 6,584 756 12.97 507 4.97 0.0224
2023-05-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 5,828 5,828 484 0.0233
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 0 -8,201 -100.00 0 -100.00
2022-11-04 2022-09-30 13F GILEAD SCIENCES COM 375558103 8,201 868 11.84 506 11.70 0.0295
2022-08-04 2022-06-30 13F GILEAD SCIENCES COM 375558103 7,333 -426 -5.49 453 -1.74 0.0253
2022-05-06 2022-03-31 13F GILEAD SCIENCES COM 375558103 7,759 357 4.82 461 -14.15 0.0222
2022-02-11 2021-12-31 13F GILEAD SCIENCES COM 375558103 7,402 230 3.21 537 7.19 0.0265
2021-11-01 2021-09-30 13F GILEAD SCIENCES COM 375558103 7,172 -436 -5.73 501 -4.39 0.0279
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 7,608 659 9.48 524 16.70 0.0287
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 6,949 -309 -4.26 449 6.15 0.0266
2021-02-11 2020-12-31 13F GILEAD SCIENCES COM 375558103 7,258 -1,030 -12.43 423 -19.27 0.0287
2020-11-04 2020-09-30 13F GILEAD SCIENCES COM 375558103 8,288 -32,560 -79.71 524 -43.78 0.0398
2020-08-06 2020-06-30 13F GILEAD SCIENCES COM 375558103 40,848 23,756 138.99 932 -27.07 0.0997
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 17,092 8,822 106.67 1,278 137.99 0.1859
2020-02-07 2019-12-31 13F GILEAD SCIENCES COM 375558103 8,270 -631 -7.09 537 -4.79 0.0234
2019-11-12 2019-09-30 13F GILEAD SCIENCES COM 375558103 8,901 475 5.64 564 -0.88 0.0689
2019-08-12 2019-06-30 13F GILEAD SCIENCES COM 375558103 8,426 219 2.67 569 6.55 0.0823
2019-05-07 2019-03-31 13F GILEAD SCIENCES COM 375558103 8,207 -632 -7.15 534 -3.44 0.0751
2019-02-12 2018-12-31 13F GILEAD SCIENCES COM 375558103 8,839 851 10.65 553 5.13 0.0979
2018-11-13 2018-09-30 13F GILEAD SCIENCES COM 375558103 7,988 765 10.59 526 19.55 0.0947
2018-08-08 2018-06-30 13F GILEAD SCIENCES COM 375558103 7,223 -350 -4.62 440 -20.72 0.0915
2018-05-15 2018-03-31 13F GILEAD SCIENCES COM 375558103 7,573 -123 -1.60 555 -3.14 0.1237
2018-02-14 2017-12-31 13F GILEAD SCIENCES COM 375558103 7,696 162 2.15 573 -7.28 0.1280
2017-11-15 2017-09-30 13F GILEAD SCIENCES COM 375558103 7,534 337 4.68 618 23.85 0.1699
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 7,197 -3,679 -33.83 499 -30.98 0.1589
2017-05-09 2017-03-31 13F GILEAD SCIENCES COM 375558103 10,876 -12,150 -52.77 723 -55.78 0.1146
2017-05-19 2016-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 23,026 23,026 1,635 0.7009
2017-02-15 2016-12-31 13F GILEAD SCIENCES Common Stock 375558103 23,026 1,635 0.6369
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.